PMF patient elderly or frail (age ≥75, ECOG ≥3, or HCT-CI ≥4) — alloHCT off the table; sy...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-PMF-FRAILTY-AGE |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | DIS-PMF |
| Sources | SRC-DIPSS-PLUS-GANGAT-2011 SRC-NCCN-MPN-2025 |
Red Flag Origin
| Definition | PMF patient elderly or frail (age ≥75, ECOG ≥3, or HCT-CI ≥4) — alloHCT off the table; symptom-directed therapy (ruxolitinib for splenomegaly + symptoms, momelotinib for anemia, transfusion + supportive care) |
|---|---|
| Clinical direction | de-escalate |
| Category | frailty-age |
| Shifts algorithm | ALGO-PMF-1L |
Trigger Logic
{
"any_of": [
{
"comparator": ">=",
"finding": "age_years",
"threshold": 75
},
{
"finding": "pmf_frail_unfit",
"value": true
},
{
"comparator": ">=",
"finding": "hct_ci_score",
"threshold": 4
},
{
"all_of": [
{
"comparator": ">=",
"finding": "ecog_performance_status",
"threshold": 3
},
{
"comparator": ">=",
"finding": "comorbidities_count",
"threshold": 2
}
]
}
],
"type": "composite"
}
Notes
AlloHCT TRM in elderly PMF >40-50% — almost always off the table. Symptom-directed JAKi as the dominant track. STUB — requires clinical co-lead signoff.
Used By
Algorithms
ALGO-PMF-1L- ALGO-PMF-1LALGO-PMF-2L- ALGO-PMF-2L
Indications
IND-PMF-1L-OBSERVATION- IND-PMF-1L-OBSERVATIONIND-PMF-1L-RUXOLITINIB- IND-PMF-1L-RUXOLITINIBIND-PMF-2L-FEDRATINIB- IND-PMF-2L-FEDRATINIBIND-PMF-ALLOHCT-HIGH-RISK- IND-PMF-ALLOHCT-HIGH-RISK